Form D · Biotechnology

toSense, Inc.

San Diego, CA · CIK 0001470006

Offering snapshot reported Feb 9, 2018 · SEC filing

Reported sold
$750K
Offering amount: $2.25M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 19, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 9, 2018Initial$750,000No comparison1SEC filing
Jun 27, 2016Initial$3,775,583No comparison4SEC filing
Dec 1, 2011Initial$3,000,000No comparison1SEC filing
Jan 26, 2010Initial$50,011No comparison1SEC filing
Aug 14, 2009InitialYet to sellNo comparison5SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-305254

Source: Form D, filed Feb 9, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Matthew Banet Director, Executive
Matt Banet Director, Executive
Robert W Cass Director, Executive
Craig Collins Director, Executive
Gregory Feld Director
Greg Feld Director
Peter Georgianna Director
Carl Hartzel Director, Executive
Kevin Hell Director
Dhillon Marshal Executive
John Melcher Director
Carl Melcher Director
Rory Moore Director
Susan Pede Executive
Alton Shader Director
Aaron Tankersley Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
9333 Genesee Avenue Ste 260
San Diego, CA, 92121